Home LiteratureArticle Details
PMID: 6975681 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Spontaneous and antibody-dependent cellular cytotoxicity by lymphocyte subpopulations in peripheral blood and spleen from adult untreated patients with Hodgkin's disease.

Clinical and experimental immunology ·Vol. 45 ·No. 1 ·1981-07-00 ·Pages 205-14

Gupta S, Fernandes G

Abstract

Subpopulations of lymphocytes in the peripheral blood and spleen from adult untreated patients with Hodgkin's disease were studied for spontaneous (SCMC) and antibody-dependent cellular cytotoxicities (ADCC). Peripheral blood from seven of 24 patients demonstrated abnormally low T cell-mediated SCMC when compared to age- and sex-matched healthy controls. Only two of these patients also demonstrated low T cell ADCC and non-T cell-mediated SCMC and ADCC. T cell ADCC in the peripheral blood of patients with involved spleen was significantly higher (P less than 0.05) when compared to those in whom spleen was not involved. When SCMC and ADCC were compared between peripheral blood and splenic lymphocytes with regard to involvement of spleen by Hodgkin's disease, non-T cell SCMC in the involved spleen was significantly lower (P less than 0.05) than their peripheral blood non-T cell SCMC. SCMC and ADCC tended to be higher in patients with stages III and IV of Hodgkin's disease when compared to those with stages I and II. However, the differences were not statistically significant. No direct relationship was observed between T and SCMC or ADCC and the proportion of T cells with IgG Fc receptors (T gamma). The significance of these observations is discussed.

MeSH Terms
Adult Antibody-Dependent Cell Cytotoxicity Cytotoxicity, Immunologic Female Hodgkin Disease/immunology,pathology Humans Leukocyte Count Lymphocytes/immunology Male Middle Aged Neoplasm Staging Spleen/immunology T-Lymphocytes/immunology
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Gupta S
Fernandes G
References (50)
50 references, click to expand
  1. Interferon, antibody, and other host factors in herpes zoster.
    J Clin Invest. 1972 May;51(5):1170-8 PMID: 5020430
  2. Hodgkin's disease and immunity.
    Am J Med. 1956 Jan;20(1):94-9 PMID: 13282926
  3. Impaired lymphocyte function in untreated Hodgkin's disease.
    N Engl J Med. 1974 Jan 24;290(4):181-6 PMID: 4203007
  4. Antibody-dependent cytotoxicity mediated by human Fc-receptor-bearing cells lacking markers for B- and T-lymphocytes.
    Int Arch Allergy Appl Immunol. 1974;47(1):139-54 PMID: 4603056
  5. In vitro leukocyte interferon production in patients with Hodgkin's disease.
    Cancer Res. 1974 Nov;34(11):2995-3002 PMID: 4421578
  6. Hodgkin's disease. An immunodepleting and immunosuppressive disorder.
    J Clin Invest. 1975 Aug;56(2):467-75 PMID: 125290
  7. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.
    Int J Cancer. 1975 Aug 15;16(2):230-9 PMID: 1080480
  8. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.
    Clin Exp Immunol. 1975 Aug;21(2):226-35 PMID: 810282
  9. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
    Cancer. 1975 Jul;36(1):169-79 PMID: 54208
  10. Lymphocyte abnormalities in untreated patients with Hodgkin's disease.
    Cancer. 1976 Feb;37(2):751-62 PMID: 1082795
  11. Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems.
    J Exp Med. 1976 Apr 1;143(4):772-80 PMID: 1082915
  12. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    N Engl J Med. 1976 Dec 2;295(23):1273-8 PMID: 185517
  13. Inhibition of T-cell rosette formation by Hodgkin-disease serum.
    N Engl J Med. 1976 Dec 2;295(23):1314-5 PMID: 185518
  14. Ecotaxis: the principle and its application to the study of Hodgkin's disease.
    Clin Exp Immunol. 1977 Jan;27(1):143-51 PMID: 300302
  15. Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin disease in continuous long remissions.
    Blood. 1977 May;49(5):771-8 PMID: 322770
  16. A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity.
    J Immunol. 1977 Jun;118(6):2058-66 PMID: 325136
  17. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.
    J Exp Med. 1977 Jul 1;146(1):184-200 PMID: 301544
  18. Binding of soluble immune complexes in serum of patients with Hodgkin's disease to tissue cultures derived from the tumor.
    N Engl J Med. 1977 Aug 11;297(6):295-9 PMID: 559938
  19. Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV1 infected target cells in disease.
    Cancer. 1977 Jul;40(1):42-5 PMID: 195708
  20. Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole.
    Clin Exp Immunol. 1977 Jul;29(1):30-5 PMID: 891036
  21. Prostaglandin-producing suppressor cells in Hodgkin's disease.
    N Engl J Med. 1977 Nov 3;297(18):963-8 PMID: 409950
  22. Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation.
    Cell Immunol. 1977 Nov;34(1):10-8 PMID: 303151
  23. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
    J Clin Invest. 1978 Jan;61(1):55-63 PMID: 304068
  24. Correlation between immune complexes and prognostic factors in Hodgkin's disease.
    Clin Exp Immunol. 1978 Feb;31(2):166-73 PMID: 648026
  25. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Scand J Haematol. 1978 Apr;20(4):306-18 PMID: 653310
  26. Natural killer cells may be the only cells in normal mouse lymphoid cell populations endowed with cytolytic ability for antibody-coated tumour target cells.
    Scand J Immunol. 1978 Apr;7(4):297-306 PMID: 418499
  27. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    J Clin Invest. 1978 Jun;61(6):1620-7 PMID: 149140
  28. Natural cell-mediated immunity.
    Adv Cancer Res. 1978;27:305-77 PMID: 356546
  29. Natural killer cells in the mouse: an alternative immune surveillance mechanism?
    Contemp Top Immunobiol. 1978;8:171-201 PMID: 80299
  30. Heterogeneity of human natural killer cell populations.
    Cell Immunol. 1978 Sep 15;40(1):58-68 PMID: 308865
  31. Natural killing and antibody-dependent cellular cytotoxicity are mediated by different mechanisms and by different cells.
    J Immunol. 1978 Nov;121(5):1956-60 PMID: 81858
  32. Augmentation of mouse natural killer cell activity by interferon and interferon inducers.
    J Immunol. 1979 Jan;122(1):175-81 PMID: 310826
  33. Spontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulations.
    Proc Natl Acad Sci U S A. 1978 Oct;75(10):5137-41 PMID: 311006
  34. Fc receptors on human T lymphocytes. II. Cytotoxic capabilities of human T gamma, T mu, B, and L cells.
    Cell Immunol. 1979 Feb;42(2):410-7 PMID: 311697
  35. Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations.
    J Immunol. 1979 Jul;123(1):252-8 PMID: 376742
  36. Immunosuppressive serum factors and lymphocyte deficiency in Hodgkin's disease.
    J Clin Lab Immunol. 1979 Feb;1(4):269-75 PMID: 501725
  37. Subpopulations of human T lymphocytes. XIV. Abnormality of T-cell locomotion and of distribution of subpopulations of T and B lymphocytes in peripheral blood and spleen from children with untreated Hodgkin's disease.
    Clin Immunol Immunopathol. 1980 Feb;15(2):133-43 PMID: 6965467
  38. Impaired monocyte-macrophage cytotoxicity in patients with Hodgkin's disease.
    Clin Immunol Immunopathol. 1980 Apr;15(4):577-85 PMID: 6244126
  39. Markers of human lymphocyte subpopulations in primary immunodeficiency and lymphoproliferative disorders.
    Semin Hematol. 1980 Jan;17(1):1-29 PMID: 6244677
  40. Inhibition of effector cell functions in natural killer cell activity (NK) and antibody-dependent cellular cytotoxicity (ADCC) in mice by normal and cancer sera.
    Int J Cancer. 1980 May 15;25(5):667-77 PMID: 7372374
  41. Concanavalin A-induced suppressor cell activity in Hodgkin's disease.
    Clin Immunol Immunopathol. 1980 Aug;16(4):454-62 PMID: 6447556
  42. Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon.
    J Immunol. 1980 Sep;125(3):1216-23 PMID: 6157721
  43. Increased monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in Hodgkin's disease.
    Br J Cancer. 1980 May;41(5):778-81 PMID: 7426302
  44. Subpopulations of human T lymphocytes. XVI. Maldistribution of T cell subsets associated with abnormal locomotion of T cells in untreated adult patients with Hodgkin's disease.
    Clin Exp Immunol. 1980 Oct;42(1):186-95 PMID: 6970098
  45. An investigation of Hodgkin's disease with respect to the problem of homotransplantation.
    Ann N Y Acad Sci. 1960 May 31;87:187-202 PMID: 13752408
  46. Impaired in vitro lymphocyte transformation in Hodgkin's disease.
    N Engl J Med. 1965 Nov 4;273(19):1006-12 PMID: 5844228
  47. Report of the Committee on Hodgkin's Disease Staging Classification.
    Cancer Res. 1971 Nov;31(11):1860-1 PMID: 5121694
  48. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients.
    Am J Med. 1972 Jan;52(1):63-72 PMID: 5058359
  49. Studies on delayed hypersensitivity in Hodgkin's disease.
    J Clin Invest. 1962 Nov;41:1964-70 PMID: 14011436
  50. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.
    Natl Cancer Inst Monogr. 1973 May;36:107-15 PMID: 4582989
Article Info
Journal
Clinical and experimental immunology
Abbr.
Clin Exp Immunol
ISSN
0009-9104
Published
1981-07-00
Pages
205-14
Language
English
Region
England
NLM ID
0057202
PMCID
PMC1537263
Subset
IM
Grants
NCI NIH HHS · CA-17404 · United States
NCI NIH HHS · CA-19267 · United States
NCI NIH HHS · CA-98748 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com